| 10065-1 |
S' wave amplitude.lead V2 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave amplitude in lead V2 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10065-1 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave Amp L-V2 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave Amp L-V2; S wave Amp L-V2; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 100650-1 |
Progress note |
Find |
Hospital |
Pt |
Doc |
Wound, ostomy, and continence care |
|
ACTIVE |
Wound, Ostomy, and Continence Care Hospital Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100650-1 |
|
Wound, ostomy, and continence care |
|
|
Both |
|
|
|
0 |
WOC Hosp Prog note |
|
|
|
N |
|
Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note; WOC |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100651-9 |
COVID-19+Intubation+Progress note |
Find |
Hospital |
Pt |
Doc |
{Role} |
|
ACTIVE |
Hospital COVID-19 Intubation Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100651-9 |
|
{Role} |
|
|
Both |
|
|
|
0 |
Hosp COVID-19 Intub+Progress |
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Intub+Progress; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100652-7 |
Pure tone bone conduction threshold audiometry panel |
- |
Ear |
Pt |
- |
|
|
ACTIVE |
Pure tone bone conduction threshold audiometry panel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CLIN |
|
100652-7 |
|
|
|
|
Order |
|
|
|
0 |
Pure tone bone thresh Pnl |
|
|
|
N |
|
CLIN; Hearing; Otologic; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Pure tone bone thresh Pnl; Random |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100653-5 |
Pure tone air conduction threshold audiometry panel |
- |
Ear |
Pt |
- |
|
|
ACTIVE |
Pure tone air conduction threshold audiometry panel |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CLIN |
|
100653-5 |
|
|
|
|
Order |
|
|
|
0 |
Pure tone air thresh Pnl |
|
|
|
N |
|
CLIN; Hearing; Otologic; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Pure tone air thresh Pnl; Random |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100654-3 |
Pyruvate kinase M2 |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Pyruvate kinase M2 [Presence] in Stool |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
100654-3 |
|
|
|
|
Both |
|
|
|
0 |
M2-PK Stl Ql |
|
|
|
N |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; M2-PK; Ordinal; PK; PKM2; Point in time; PR; Pyruvic acid; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100655-0 |
View lateral |
Find |
Head>Sella turcica |
Pt |
Doc |
XR |
|
ACTIVE |
XR Sella turcica Lateral |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
100655-0 |
|
XR |
|
|
Both |
|
|
|
0 |
XR ST Lat |
|
|
|
N |
|
1V; Brain; Cranial; Cranium; Document; Film; Finding; Findings; Imaging; Intracranial; Lat; Plain Films; Point in time; Radiology; Random; Single View; Skull; ST; VW; Xray; X-ray |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100656-8 |
Progress note |
Find |
Outpatient |
Pt |
Doc |
Maternal and fetal medicine |
|
ACTIVE |
Maternal and fetal medicine Outpatient Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100656-8 |
|
Maternal and fetal medicine |
|
|
Both |
|
|
|
0 |
Mat fetal med OP Prog note |
|
|
|
N |
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100657-6 |
Progress note |
Find |
Telephone encounter+Hospital |
Pt |
Doc |
Maternal and fetal medicine |
|
ACTIVE |
Maternal and fetal medicine Telephone encounter+Hospital Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100657-6 |
|
Maternal and fetal medicine |
|
|
Both |
|
|
|
0 |
Mat fetal med Phone+Hosp Prog note |
|
|
|
N |
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Mat fetal med; notes; Phone+Hosp; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100658-4 |
COVID-19+Progress note |
Find |
Hospital |
Pt |
Doc |
|
|
ACTIVE |
Hospital COVID-19 Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100658-4 |
|
|
|
|
Both |
|
|
|
0 |
Hosp COVID-19 Progress note |
|
|
|
N |
|
2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Progress note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Prog note; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100659-2 |
Progress note |
Find |
Hospital |
Pt |
Doc |
Maternal and fetal medicine |
|
ACTIVE |
Maternal and fetal medicine Hospital Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100659-2 |
|
Maternal and fetal medicine |
|
|
Both |
|
|
|
0 |
Mat fetal med Hosp Prog note |
|
|
|
N |
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; Mat fetal med; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10066-9 |
S' wave amplitude.lead V3 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave amplitude in lead V3 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10066-9 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave Amp L-V3 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave Amp L-V3; S wave Amp L-V3; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 100660-0 |
Progress note |
Find |
Telephone encounter+Outpatient |
Pt |
Doc |
Maternal and fetal medicine |
|
ACTIVE |
Maternal and fetal medicine Telephone encounter+Outpatient Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100660-0 |
|
Maternal and fetal medicine |
|
|
Both |
|
|
|
0 |
Mat fetal med Phone+OP Prog note |
|
|
|
N |
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; OP; Phone+OP; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100661-8 |
Progress note |
Find |
Outpatient |
Pt |
Doc |
Psychiatry |
|
ACTIVE |
Psychiatry Outpatient Progress note |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
100661-8 |
|
Psychiatry |
|
|
Both |
|
|
|
0 |
Psychiatric OP Prog note |
|
|
|
N |
|
DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Prog note; Psychiatric; Random; subsequent evaluation; subsequent visit evaluation; Visit note |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100662-6 |
Cortisol free & total panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Cortisol free and total panel - Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
100662-6 |
|
|
|
|
Order |
|
|
|
0 |
CORTO SerPl |
|
|
|
N |
|
17-Hydroxycorticosterone; Chemistry; Compound F; Coritsol; Cort; Cortis F; CORTO; F; FR; hydrocortisone; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl |
2.73 |
2.73 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 100663-4 |
TPMT gene c.460G>A&c.719A>G |
PrThr |
Bld |
Pt |
Ord |
Molgen |
|
ACTIVE |
TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.PHARMG |
|
100663-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
TPMT gene c.460G>A&c.719A>G Bld Ql |
|
|
|
N |
|
Ala154Thr; Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; rs1800460; Screen; thiopurine S-methyltransferase; Thiopurine S-methyltransferase gene; TPMT c.460G>A; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100664-2 |
NUDT15 gene c.50_55dup&c.415C>T |
PrThr |
Bld |
Pt |
Ord |
Molgen |
|
ACTIVE |
NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100664-2 |
|
Molgen |
|
|
Both |
|
|
|
0 |
NUDT15 gene c.50_55dup&c.415C>T Bld Ql |
|
|
|
N |
|
Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100665-9 |
NUDT15 gene c.415C>T |
PrThr |
Bld |
Pt |
Ord |
Molgen |
|
ACTIVE |
NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100665-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
NUDT15 gene c.415C>T Bld Ql |
|
|
|
N |
|
Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100666-7 |
NUDT15 gene c.416G>A |
PrThr |
Bld |
Pt |
Ord |
Molgen |
|
ACTIVE |
NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100666-7 |
|
Molgen |
|
|
Both |
|
|
|
0 |
NUDT15 gene c.416G>A Bld Ql |
|
|
|
N |
|
Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100667-5 |
NUDT15 gene c.52G>A |
PrThr |
Bld |
Pt |
Ord |
Molgen |
|
ACTIVE |
NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100667-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
NUDT15 gene c.52G>A Bld Ql |
|
|
|
N |
|
Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100668-3 |
NUDT15 gene c.50_55dup |
PrThr |
Bld |
Pt |
Ord |
Molgen |
|
ACTIVE |
NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100668-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
NUDT15 gene c.50_55dup Bld Ql |
|
|
|
N |
|
Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100669-1 |
NUDT15 gene c.50_55del |
PrThr |
Bld |
Pt |
Ord |
Molgen |
|
ACTIVE |
NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
100669-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
NUDT15 gene c.50_55del Bld Ql |
|
|
|
N |
|
Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10067-7 |
S' wave amplitude.lead V4 |
Elpot |
Heart |
Pt |
Qn |
EKG |
|
ACTIVE |
S' wave amplitude in lead V4 |
|
MIN |
DefinitionDescription |
|
|
mV |
|
|
|
|
|
|
EKG.MEAS |
|
10067-7 |
|
EKG |
|
|
Observation |
|
|
|
0 |
S' wave Amp L-V4 |
|
|
|
Y |
|
Cardiac; Cardio; Cardiology; ECG; EKG.MEASUREMENTS; Electrical potential; Electrocardiogram; Electrocardiograph; Heart Disease; Hrt; Painter's colic; PB; Plumbism; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; S' wave Amp L-V4; S wave Amp L-V4; Voltage |
2.48 |
1.0i |
|
|
|
|
|
|
|
mV |
|
|
|
0 |
| 100670-9 |
RHD gene allele^fetus |
Prid |
Plas.cfDNA |
Pt |
Nom |
|
|
ACTIVE |
RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
100670-9 |
|
|
|
|
Both |
|
|
|
0 |
RHD allele fetus Plas.cfDNA |
|
|
|
N |
|
CD240D; CD240D gene; DIIIc; Identity or presence; Molecular pathology; MOLPATH; Nominal; Pl; Plasma; Plsm; Point in time; Random; RH; Rh blood group gene, D antigen; Rh blood group, D antigen; RH30; Rh4; RHCED; RHD allele; RhD type IIIa protein gene; RhDCw; RHDel; RHDVA(TT); Rhesus blood group, D antigen; RhII; RhK562-II; RHPI; RHPII; RHXIII |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 100671-7 |
Aspergillus sp DNA |
PrThr |
Bld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Aspergillus sp DNA [Presence] in Blood by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
100671-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Aspergillus DNA Bld Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Farmers lung; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood |
2.73 |
2.73 |
|
|
|
|
|
|
|
|
|
|
|
0 |